GMOD seeks positive total return through a dynamic, multi-asset allocation approach that adjusts exposures across equities, fixed income, and liquid alternative strategies based on GMOs long-term valuation and risk outlook. The fund typically operates as a fund of funds, investing mainly in other GMO-managed and third-party vehicles but may also hold securities directly. Allocation decisions are guided by GMOs forecasts of expected returns and its view that valuations tend to revert to fair value over time. This forward-looking process incorporates assessments of relative risk, economic trends, and market conditions to determine where capital is best positioned. The portfolios flexibility allows allocations to shift meaningfully, with equity exposure generally ranging between 40% and 80% of net assets. While diversified across asset classes, the fund can concentrate in certain markets or sectors when valuation signals support a higher conviction stance.
—
GMOD seeks positive total return through a dynamic, multi-asset allocation approach that adjusts exposures across equities, fixed income, and liquid alternative strategies based on GMOs long-term valuation and risk outlook. The fund typically operates as a fund of funds, investing mainly in other GMO-managed and third-party vehicles but may also hold securities directly. Allocation decisions are guided by GMOs forecasts of expected returns and its view that valuations tend to revert to fair value over time. This forward-looking process incorporates assessments of relative risk, economic trends, and market conditions to determine where capital is best positioned. The portfolios flexibility allows allocations to shift meaningfully, with equity exposure generally ranging between 40% and 80% of net assets. While diversified across asset classes, the fund can concentrate in certain markets or sectors when valuation signals support a higher conviction stance.
—
Daily adjusted close
GMOD seeks positive total return through a dynamic, multi-asset allocation approach that adjusts exposures across equities, fixed income, and liquid alternative strategies based on GMOs long-term valuation and risk outlook. The fund typically operates as a fund of funds, investing mainly in other GMO-managed and third-party vehicles but may also hold securities directly. Allocation decisions are guided by GMOs forecasts of expected returns and its view that valuations tend to revert to fair value over time. This forward-looking process incorporates assessments of relative risk, economic trends, and market conditions to determine where capital is best positioned. The portfolios flexibility allows allocations to shift meaningfully, with equity exposure generally ranging between 40% and 80% of net assets. While diversified across asset classes, the fund can concentrate in certain markets or sectors when valuation signals support a higher conviction stance.